Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms

被引：0
作者：
Barbosa Pagnano, Katia Borgia [1 ]
机构：
[1] Univ Estadual Campinas Unicamp, Campinas, SP, Brazil
来源：
HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2018年 / 40卷 / 02期
关键词：
D O I：
10.1016/j.htct.2018.01.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 9 条
[1]   Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 [J].
Barbui, Tiziano ;
Carobbio, Alessandra ;
Finazzi, Guido ;
Vannucchi, Alessandro M. ;
Barosi, Giovanni ;
Antonioli, Elisabetta ;
Guglielmelli, Paola ;
Pancrazzi, Alessandro ;
Salmoiraghi, Silvia ;
Zilio, Pio ;
Ottomano, Cosimo ;
Marchioli, Roberto ;
Cuccovillo, Ivan ;
Bottazzi, Barbara ;
Mantovani, Alberto ;
Rambaldi, Alessandro .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02) :315-318
[2]   Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [J].
Cacemiro, Maira da Costa ;
Cominal, Jucara Gastaldi ;
Tognon, Raquel ;
Nunes, Natalia de Souza ;
Simoes, Belinda Pinto ;
de Figueiredo-Pontes, Lorena Lobo ;
Bazzo Catto, Luiz Fernando ;
Traina, Fabiola ;
Souto, Elizabeth Xisto ;
Zambuzi, Fabiana Albani ;
Frantz, Fabiani Gai ;
de Castro, Fabiola Attie .
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) :120-131
[3]   Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms [J].
Hoermann, Gregor ;
Cerny-Reiterer, Sabine ;
Herrmann, Harald ;
Blatt, Katharina ;
Bilban, Martin ;
Gisslinger, Heinz ;
Gisslinger, Bettina ;
Muellauer, Leonhard ;
Kralovics, Robert ;
Mannhalter, Christine ;
Valent, Peter ;
Mayerhofer, Matthias .
FASEB JOURNAL, 2012, 26 (02) :894-906
[4]   The role of the extracellular matrix in primary myelofibrosis [J].
Leiva, O. ;
Ng, S. K. ;
Chitalia, S. ;
Balduini, A. ;
Matsuura, S. ;
Ravid, K. .
BLOOD CANCER JOURNAL, 2017, 7 :e525-e525
[5]   Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera [J].
Lussana, Federico ;
Carobbio, Alessandra ;
Salmoiraghi, Silvia ;
Guglielmelli, Paola ;
Vannucchi, Alessandro Maria ;
Bottazzi, Barbara ;
Leone, Roberto ;
Mantovani, Alberto ;
Barbui, Tiziano ;
Rambaldi, Alessandro .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 :1-8
[6]   Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications [J].
Pourcelot, Emmanuel ;
Trocme, Candice ;
Mondet, Julie ;
Bailly, Sebastien ;
Toussaint, Bertrand ;
Mossuz, Pascal .
EXPERIMENTAL HEMATOLOGY, 2014, 42 (05) :360-368
[7]   Pathogenesis of myelofibrosis with myeloid metaplasia [J].
Tefferi, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8520-8530
[8]   Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study [J].
Tefferi, Ayalew ;
Vaidya, Rakhee ;
Caramazza, Domenica ;
Finke, Christy ;
Lasho, Terra ;
Pardanani, Animesh .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :1356-1363
[9]   Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis. [J].
Verstovsek, Srdan ;
Kantarjian, Hagop ;
Mesa, Ruben A. ;
Pardanani, Animesh D. ;
Cortes-Franco, Jorge ;
Thomas, Deborah A. ;
Estrov, Zeev ;
Fridman, Jordan S. ;
Bradley, Edward C. ;
Erickson-Viitanen, Susan ;
Vaddi, Kris ;
Levy, Richard ;
Tefferi, Ayalew .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12) :1117-1127
1